181 related articles for article (PubMed ID: 29084638)
61. Dendritic cells induce the death of human papillomavirus-transformed keratinocytes.
Hubert P; Giannini SL; Vanderplasschen A; Franzen-Detrooz E; Jacobs N; Boniver J; Delvenne P
FASEB J; 2001 Nov; 15(13):2521-3. PubMed ID: 11641258
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of specific humoral and cellular immune responses against the major capsid L1 protein of cutaneous wart-associated alpha-Papillomaviruses in solid organ transplant recipients.
Gaiser MR; Textor S; Senger T; Schädlich L; Waterboer T; Kaufmann AM; Süsal C; Pawlita M; Enk AH; Gissmann L; Lonsdorf AS
J Dermatol Sci; 2015 Jan; 77(1):37-45. PubMed ID: 25439730
[TBL] [Abstract][Full Text] [Related]
63. Interleukin-33 is expressed in the lesional epidermis in herpes virus infection but not in verruca vulgaris.
Jin M; Komine M; Tsuda H; Oshio T; Ohtsuki M
J Dermatol; 2018 Jul; 45(7):855-857. PubMed ID: 29696682
[TBL] [Abstract][Full Text] [Related]
64. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
[TBL] [Abstract][Full Text] [Related]
65. A genotype distribution of human papillomaviruses detected by polymerase chain reaction and direct sequencing analysis in a large sample of common warts in Japan.
Hagiwara K; Uezato H; Arakaki H; Nonaka S; Nonaka K; Nonaka H; Asato T; Oshiro M; Kariya K; Hattori A
J Med Virol; 2005 Sep; 77(1):107-12. PubMed ID: 16032719
[TBL] [Abstract][Full Text] [Related]
66. Treatment of cutaneous warts: an evidence-based review.
Dall'oglio F; D'Amico V; Nasca MR; Micali G
Am J Clin Dermatol; 2012 Apr; 13(2):73-96. PubMed ID: 22292461
[TBL] [Abstract][Full Text] [Related]
67. Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia.
Gaspari AA; Zalka AD; Payne D; Menegus M; Bunce LA; Abboud CN; Tyring SK
Arch Dermatol; 1997 Apr; 133(4):491-6. PubMed ID: 9126013
[TBL] [Abstract][Full Text] [Related]
68. Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.
Haftek M; Jabłonska S; Orth G
Dermatologica; 1985; 170(5):213-20. PubMed ID: 2989014
[TBL] [Abstract][Full Text] [Related]
69. Warts and all: human papillomavirus in primary immunodeficiencies.
Leiding JW; Holland SM
J Allergy Clin Immunol; 2012 Nov; 130(5):1030-48. PubMed ID: 23036745
[TBL] [Abstract][Full Text] [Related]
70. Density of viral particles in pre and post Nd: YAG laser hyperthermia therapy and cryotherapy in plantar warts.
El-Tonsy MH; Anbar TE; El-Domyati M; Barakat M
Int J Dermatol; 1999 May; 38(5):393-8. PubMed ID: 10369554
[TBL] [Abstract][Full Text] [Related]
71. Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.
Sumi E; Nomura T; Asada R; Uozumi R; Tada H; Amino Y; Sawada T; Yonezawa A; Hagiwara M; Kabashima K
Clin Drug Investig; 2019 Jan; 39(1):55-61. PubMed ID: 30284700
[TBL] [Abstract][Full Text] [Related]
72. Extragenital cutaneous warts - clinical presentation, diagnosis and treatment.
Abeck D; Tetsch L; Lüftl M; Biedermann T
J Dtsch Dermatol Ges; 2019 Jun; 17(6):613-634. PubMed ID: 31241843
[TBL] [Abstract][Full Text] [Related]
73. Intralesional 2% zinc sulfate solution for plane warts: A case report.
El Taweel AA; Salem R; Allam A
Dermatol Ther; 2019 Jan; 32(1):e12761. PubMed ID: 30288881
[TBL] [Abstract][Full Text] [Related]
74. HPV Vaccine for Treatment of Recalcitrant Cutaneous Warts in Adults: A Retrospective Cohort Study.
Waldman A; Whiting D; Rani M; Alam M
Dermatol Surg; 2019 Dec; 45(12):1739-1741. PubMed ID: 31765341
[No Abstract] [Full Text] [Related]
75. Serum level of interleukin-22 in patients with cutaneous warts: A case-control study.
Marie REM; Abuzeid AQEM; Attia FM; Anani MM; Gomaa AHA; Atef LM
J Cosmet Dermatol; 2021 Jun; 20(6):1782-1787. PubMed ID: 33043549
[TBL] [Abstract][Full Text] [Related]
76. Immune Modulation and Treatment of Human Papilloma Virus-Related Warts with Energetics of Living Systems Acupuncture.
Brustin R; Toledano M; Geffen T; Goona R; Hochberg M; Kreisberg B; Murad S; Pitcovski J
Med Acupunct; 2017 Jun; 29(3):145-154. PubMed ID: 28736591
[No Abstract] [Full Text] [Related]
77. Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient.
Erkayman MH; Bilen H
Transpl Infect Dis; 2021 Aug; 23(4):e13572. PubMed ID: 33507618
[TBL] [Abstract][Full Text] [Related]
78. Microwave therapy for the treatment of plantar warts.
Hagon W; Hagon J; Noble G; Brenton-Rule A; Stewart S; Bristow I
J Foot Ankle Res; 2023 Jun; 16(1):37. PubMed ID: 37322512
[TBL] [Abstract][Full Text] [Related]
79. The SILVER study. Efficacy of topical nitric-zinc complex solution in the treatment of resistant warts: A postmarketing evaluation.
Puviani M; Manfredini M; Eisendle K
Dermatol Ther; 2019 Jul; 32(4):e12940. PubMed ID: 30990239
[TBL] [Abstract][Full Text] [Related]
80. The treatment of plantar warts using microwave-A review of 85 consecutive cases in the United States.
Gupta AK; Wang T; Cooper EA; Conenello RM; Bristow IR
J Cosmet Dermatol; 2023 Oct; 22(10):2729-2736. PubMed ID: 37340590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
